DNA methylation analysis can help researchers gain valuable insight into gene regulation and identify potential biomarkers. Aberrant DNA methylation has been implicated in many disease processes, including cancer, obesity, and addiction. DNA methylation is also a common subject of agrigenomic investigations into responses to drought, temperature extremes, and other environmental changes.
High-throughput technologies such as next-generation sequencing (NGS) and microarrays enable genome-wide methylation profiling studies. These technologies offer new ways to understand the significance of DNA methylation, providing novel insights into the functional consequences of variation.
Methylation Sequencing with NGSNGS enables comprehensive profiling of methylation patterns at single-base resolution across the whole genome, or in targeted epigenetic regions of interest. |
Methylation MicroarraysArrays enable quantitative interrogation of selected methylation sites across the genome, offering high-throughput capabilities that minimize the cost per sample. |
|
Most important to me | Comprehensive methylome coverage | High throughput (large sample numbers) |
Least important to me | Throughput | Coverage |
#CpGs covered | ~36 million CpGs (whole genome) ~3.3. million CpGs (targeted) |
~850,000 CpGs |
Species | All (whole genome) Human (targeted) |
Human |
Learn More About Methylation Sequencing | Learn More About Methylation Arrays |
Methylation analysis and RNA-Seq help researchers understand how endurance training makes epigenetic changes to the human genome.
Read InterviewTargeted methylation sequencing identifies epigenetic signatures that correlate with brain image scans of substance abusers.
Read InterviewStudies of epigenetic alterations in cancer, such as aberrant methylation and transcription factor binding, can provide insight into important tumorigenic pathways. Learn more about cancer epigenetics research.
Genome-wide DNA methylation analysis can help researchers understand the functional mechanisms at work in complex diseases such as Alzheimer’s disease or asthma. Learn more about complex disease research.
An overview of the impact of cytosine methylation and the primary methods used to detect cytosine modifications.
Researchers explore cancer subtypes using Illumina technology for whole-exome, whole-genome, and whole-epigenome sequencing.
A collection of research papers that systematically characterize epigenomic landscapes in primary human tissues and cells.
A consortium generating 100 reference epigenomes to understand gene activation and repression in healthy and diseased human cells.
TruSeq Methyl Capture EPIC rapidly produces target enrichment-based bisulfite sequencing libraries from human DNA samples.
Researchers investigate the epigenetics behind cancer metastasis using DNA methylation microarrays and NGS.